LOS ALTOS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the ...
An observational study suggests that administration of phosphorus binders dramatically improves survival rates in patients on incident hemodialysis—even in those without hyperphosphatemia. Randomized ...
For patients on dialysis, taking medications to reduce levels of the mineral phosphorus in the blood may reduce the risk of death by 25 to 30 percent, reports a study in the Journal of the American ...
The problem of phosphate accumulation became apparent quite early in the history of dialysis. Soft tissue and vascular calcification could often be clearly visualised on plain x-ray because of calcium ...
Please provide your email address to receive an email when new articles are posted on . Of survey respondents, 47% said large number and large size of pills were among top phosphate binder adherence ...
Few areas related to the care of patients on dialysis have generated more controversy than the use of phosphate binders. The current debate regarding use of calcium-based versus non-calcium-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results